Galmed Pharmaceuticals Stock Investor Sentiment

GLMD Stock  USD 2.68  0.02  0.74%   
About 62% of Galmed Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Galmed Pharmaceuticals stock suggests that many investors are alarmed at this time. The current market sentiment, together with Galmed Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Galmed Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
over a year ago at news.google.com         
This Week in Health News 11 Stories You Need to See - Benzinga
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Galmed Pharmaceuticals Q1 Earnings Snapshot
Yahoo News
over a year ago at finance.yahoo.com         
Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Developments
Yahoo News
over a year ago at news.google.com         
Global Nonalcoholic Steatohepatitis Therapeutics Market Report 2023 Featuring Pfizer, Inventiva, - B...
Google News at Macroaxis
over a year ago at Macroaxis         
Breaking down Galmed (USA Stocks:GLMD) volatility
Macroaxis News
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Now Covered by StockNews.com
news
over a year ago at news.google.com         
The Rising NAFLDNASH Epidemic Coupled with High Patient Need Offers Opportunities for Pharmaceutical...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Galmed Pharmaceuticals
news
over a year ago at news.google.com         
Is Galmed Pharmaceuticals Ltd a Stock to Watch After Losing -14.66 percent This Week - InvestorsObse...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Ltd. Sees Large Drop in Short Interest
news
over a year ago at simplywall.st         
Is Galmed Pharmaceuticals In A Good Position To Deliver On Growth Plans?
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
StockNews.com Initiates Coverage on Galmed Pharmaceuticals ... - MarketBeat
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Galmed Pharmaceuticals
news
over a year ago at finance.yahoo.com         
Galmed Announces Initiation of a Clinical Development Program to Evaluate Aramchol meglumine for the...
Yahoo News
over a year ago at news.google.com         
Do not use FDA issues warning about recalled COVID-19 tests due ... - msnNOW
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Galmed Pharmaceuticals that are available to investors today. That information is available publicly through Galmed media outlets and privately through word of mouth or via Galmed internal channels. However, regardless of the origin, that massive amount of Galmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Galmed Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Galmed Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Galmed Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Galmed Pharmaceuticals alpha.

Galmed Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Galmed Stock analysis

When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing